I qualified in medicine in 1991 from Cambridge and Oxford. Junior doctor jobs took me from Oxford to Bristol, Bath, Torbay and Australia, including work with the Royal Flying Doctor Service. On my return to the UK I entered Public Health, working in Somerset before moving to Cambridge and subsequently UEA. I was awarded an MRC Fellowship in 2001 and have gained almost £4 million as a principal investigator and over £10 million as a co-applicant, principally funding randomised controlled trials in pharmacy practice and substance misuse.
I have always had a passion for teaching, playing an active role in UEA's new, innovative integrated medical course. I became its Course Director in 2008 and Deputy Head of School in 2012. I was appointed Head of Leicester Medical School in 2017 and have worked with our excellent team to deliver a new curriculum designed by Nick London et al with a strong focus on clinical apprenticeship training. Despite COVID we have bedded in the new curriculum, grown our intake by over 30%; made gains in student satisfaction (now top 10), and improved preparedness of our graduates.
My national roles have included Chair of the Diplomate exam (previously known as Part A, MFPH), for the Faculty of Public Health (FPH) and I now chair the Diplomate Exam Development Committee, FPH.
I am a Health Services researcher with a focus on randomised controlled trials of pragmatic interventions and systematic reviews. My research has focused on pharmacy practice, particularly assessing extended roles for pharmacists; and substance misuse - notably supervised consumption in opiate dependence, and more recently the roles e-cigarettes in smoking cessation and relapse prevention in collaboration with Prof. Caitlin Notley and other colleagues at UEA. My most recent major award was a large 5-year NIHR programme grant with Prof. David Wright and colleagues, testing the effectiveness of a pharmacist independent prescribing intervention within care homes across England, Scotland and Northern Ireland.
1. Notley C, Kouimtsidis C, et al: An exploration of Identity Change in Post-Detoxification Alcohol Dependent Individuals. Drug & Alcohol Today, accepted October 2021
2. Wright D. J et al Development and feasibility testing of an evidence-based training programme for pharmacist independent prescribers responsible for the medicines-related activities within care homes. IJPP 2021 Aug 11;29(4):376-384. doi: 10.1093/ijpp/riab025.
3. Naughton F, Ward E, Khondoker M, Belderson P, Minihane A, Dainty J, Hanson S, Holland R, Brown T, Notley C: Health behaviour change during the UK COVID-19 lockdown: findings from the first wave of the C-19 health behaviour and wellbeing daily tracker study". 2021; 26(2):624-643. doi: 10.1111/bjhp.12500
4. Ward E, Dawkins L, Holland R, Notley C. Responsibility, normalisation and negotiations of harm: e-cigarette users’ opinions and experiences of vaping around children. International J Drug Policy 88 (2021) 103016
5. Brown TJ, Gentry S, Bauld L, Boyle EM, Clarke P, Hardeman W, Holland R, Naughton F, Orton S, Ussher M, Notley C. Systematic review of behaviour change techniques within interventions to reduce environmental tobacco smoke exposure for children. Int J Environ Res Public Health 2020 Oct 22;17(21):7731. doi: 10.3390/ijerph17217731.
6. Gentry S, Ward E, Dawkins L, Holland R, Notley C. Reported patterns of vaping to support long-term abstinence from smoking: a cross-sectional survey of a convenience sample of vapers. Harm Reduct J 17, 70 (2020). https://doi.org/10.1186/s12954-020-00418-8
7. Ward E, Dawkins L, Holland R, Notley C. “I don’t do it in front of the children”: qualitative analysis of electronic cigarette users’ opinions and reported experiences of vaping around children. Int J Drug Policy (accepted Sept 2020)
8. Notley C, Ward E, Dawkins L, Holland R. User pathways of e-cigarette use to support long term tobacco smoking relapse prevention: A qualitative analysis. Addiction 2020, 116, 596–605
9. Desborough J, Clark A, Houghton J, Sach T, Shaw V, Kirthisinga V, Holland R, Wright D. Clinical and cost effectiveness of a multi‐professional medication reviews in care homes (CAREMED): IJPP 2020, 28, pp. 626–634 https://doi.org/10.1111/ijpp.12656
10. Ward E, Anholt C, Gentry S, Dawkins L, Holland R, Notley C. A qualitative exploration of consumers’ perceived impacts, behavioural reactions, and future reflections of the EU Tobacco Products Directive (2017) as applied to electronic cigarettes. Tobacco Use Insights 2020, 13, 1-9. doi.org/10.1177%2F1179173X20925458
11. Lane K, Bond C.M., Wright, D, Alldred D, Desborough D, Holland R, Hughes C, Poland F. Everyone needs to understand each other's systems": Stakeholder views on the acceptability and viability of a Pharmacist Independent Prescriber role in care homes for older people in the UK. Health & Social Care in the Community: Mar 2020: doi.org/10.1111/hsc.12970
12. Söreskog E, Borgström F, Shepstone L, Clarke S, Cooper C, Harvey I, Harvey NC, Howe A, Johansson H, Marshall T, O'Neill TW, Peters TJ, Redmond NM, Turner D, Holland R, McCloskey E, Kanis JA; SCOOP study team. Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Osteoporosis International 2020 Aug; 31(8):1499-1506. doi: 10.1007/s00198-020-05372-6. Epub 2020 Apr 1.
13. Condurache C, Chiu S, Chotiyarnwong P, Johansson H, Shepstone L, Lenaghan E, Cooper C, Clarke S, Khioe RFS, Fordham R, Gittoes N, Harvey I, Harvey NC, Heawood A, Holland R, Howe A, Kanis JA, Marshall T, O'Neill TW, Peters TJ, Redmond NM, Torgerson D, Turner D, McCloskey E. Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study. Osteoporosis International, Jan 2020: 31(3): 457–464
14. Wright D, Maskrey V, Blyth A, Norris N, Alldred D, Bond C M, Desborough J, Hughes CM, Holland R: Systematic review and narrative synthesis of pharmacist provided medicines optimisation services in care homes for older people to inform the development of a generic training or accreditation process. Int J Pharm Pract 2020 Jun; 28(3):207-219. doi: 10.1111/ijpp.12591.
15. Bond CM, Holland RC, Arthur A, Alldred D, Barton G, Blyth A, Desborough J, Ford J, Handford C, Hill H, Hughes C, Maskrey V, Norris N, Myint P, Poland F, Shepstone L, Turner D, Zermansky A, Wright D. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study. Trials 21, 103 (2020). doi.org/10.1186/s13063-019-3827-0
16. Brown TJ, Bauld L, Hardeman W, Holland R, Naughton F, Orton S, Ussher M, Notley C: Re-configuring Identity Postpartum and Sustained Abstinence or Relapse to Tobacco Smoking. Int. J. Environ. Res. Public Health 2019, 16(17), 3139; https://doi.org/10.3390/ijerph16173139
17. Inch J; Notman F; Bond C; Alldred D,; Arthur A; Blyth A; Daffu-O’Reilly A; Ford J; Hughes C; Maskrey V; Millar A; Myint P; Poland F; Shepstone L; Zermansky A; Holland R; Wright D: The Care Home Independent Prescribing Pharmacist Study (CHIPPS)-A non-randomised feasibility study of independent pharmacist prescribing in care homes. Pilot and Feasibility Studies: (2019) 5:89. https://doi.org/10.1186/s40814-019-0465-y
18. Notley C, Brown T, Bauld L, Hardeman W, Holland R, Naughton F, Orton S, Ussher M: Development of a complex intervention for the maintenance of postpartum smoking abstinence: Process for defining evidence-based intervention. Int J Env Res Public Health. 2019: (16) 1968 doi:10.3390/ijerph16111968
19. Kidd A, Honney K, Bowker L, Clark A, Myint P, Holland R. Doctors are inconsistent in estimating survival after CPR and are not using such predictions consistently in determining DNACPR decisions. Geriatrics 2019 May 3;4(2). pii: E33. doi: 10.3390/geriatrics4020033
20. Kouimtsidis C, Houghton B; Gage H, Notley C, Maskrey V; Clark A; Holland R, Lingford-Hughes, Punukollu B; Duka T: A Feasibility Study of an Intervention for Structured Preparation before Detoxification in Alcohol Dependence: the SPADe trial protocol. Pilot Feasibility Stud 5, 59 (2019) doi:10.1186/s40814-019-0446-1
21. Notley C, Ward E, Dawkins L, Holland R, Jakes S. Vaping as an alternative to smoking relapse following brief lapse. Drug & Alcohol Review: (January 2019), 38, 68–75. DOI: 10.1111/dar.12876
22. Brown T, Hardeman W, Bauld L, Holland R, Maskrey V, Naughton, F, Orton S, Ussher, M, Notley, C. A systematic review of behaviour change techniques within interventions to prevent return to smoking postpartum. Addictive Behaviors 2019 May; 92:236-243. doi: 10.1016/j.addbeh.2018.12.031.
23. Sach T, Desborough J, Houghton J, and Holland R. A comparison of two sources of primary and social care resource use data in a care home setting. Unit costs of Health and Social Care: 2018, 8-18. https://www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2018/
24. Parsons, C, Harvey, NC, Shepstone, L, Kanis, JA, Lenaghan, E, et al. ‘Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: An analysis of the UK SCOOP Trial’. Osteoporosis International. 2019: 1-9. (doi:10.1007/s00198-019-05142-z).
25. Nagraj S, Miles S, Bryant P, Holland R: Medical Students’ Views About Having Different Types of Problem-Based Learning Tutors. Medical Science Educator 2019, Vol 29 (1), p93-100, DOI: 10.1007/s40670-018-00634-9
26. Notley C, Ward E, Dawkins L, Holland R. The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention. Harm Reduction Journal 2018: 15; 31 doi.org/10.1186/s12954-018-0237-7
27. McCloskey E, Johansson H, Harvey N, Shepstone L, Lenaghan E, Fordham F et al: Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures – a post hoc analysis of the SCOOP Study: J Bone Miner Res. 2018 Jun; 33(6):1020-1026. doi: 10.1002/jbmr.3411.
28. Ward E, Cox S, Dawkins L, Jakes S, Holland R, Notley C. A qualitative exploration of the role of vape shop environments in supporting smoking abstinence. Int. J. Environ. Res. Public Health 2018, 15(2), 297; doi:10.3390/ijerph15020297
29. *Turner D et al: The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK: economic evaluation of the SCOOP study JBMR Vol. 33, 2018, pp 1–7 DOI: 10.1002/jbmr.3381
30. *Shepstone L. et al: A Randomized Controlled Trial of Screening in the Community to Reduce Fractures in Older Women: The SCOOP Study. Lancet 2018: 391, No. 10122, p741–747
31. Gentry S, Craig J, Holland R & Notley C: Smoking cessation for substance misusers: a systematic review of qualitative studies on participant and provider beliefs and perceptions. Drug and Alcohol Dependence 180C (2017) pp. 178-192 DOI: 10.1016/j.drugalcdep.2017.07.043
32. Millar A; Daffu-O'Reilly A; Hughes C; Alldred D; Barton G; Bond C; Desborough J; Myint P; Holland R; Poland F; Wright D: Development of a Core Outcome Set for effectiveness trials aimed at optimising prescribing in older adults in care homes; CHIPPS Team. Trials 2017 18:175 https://doi.org/10.1186/s13063-017-1915-6
33. Cadman B, Wright D, Bale A, Barton G, Desborough J, Hammad EA, Holland R, Howe H, Nunney I, Irvine L: Pharmacist provided medicines reconciliation within 24 hours of admission and on discharge: a randomised controlled pilot study. BMJ Open 7 (3) e013647 March 2017
34. Notley C, Blyth A, Maskrey V, Karavadra B, Brown T, Holland R, Bachmann M, Brandon T, Song F. Self-help materials for smoking relapse prevention: A process evaluation of the SHARPISH randomised controlled trial. J Public Health (Oxf), 2/2017: 1-8.DOI: https://doi.org/10.1093/pubmed/fdx013
35. Song, F., Maskrey, V., Blyth, A., Brown, T., Barton, G., Aveyard, P., Notley, C., Holland, R., Bachmann, M., Sutton, S., Brandon, T. Differences in longer-term smoking abstinence after treatment by specialist or non-specialist advisors – secondary analysis of data from a relapse prevention trial, in Nicotine and Tobacco Research (2016) 18 (5), 1061-1066
36. Inch, J., Porteous, T., Maskrey, V., Blyth, A., Burr, J., Cleland, J., Wright, D. J., Holland, R., Bond, C. M. and Watson, M. C. (2016), It's not what you do it's the way that it's measured: quality assessment of minor ailment management in community pharmacies. Int J Pharm Pract. doi:10.1111/ijpp.12305
37. Bhattacharya D, Aldus CF, Barton G, Bond CM, Boonyaprapa S, Charles IS, Fleetcroft R, Holland R, Jerosch-Herold C, Salter C, Shepstone L, Walton C, Watson S, Wright DJ. The feasibility of determining the effectiveness and cost-effectiveness of medication organisation devices compared with usual care for older people in a community setting: systematic review, stakeholder focus groups and feasibility randomised controlled trial. HTA Vol 20, Issue: 50. July 2016. DOI: http://dx.doi.org/10.3310/hta20500
38. Elwell-Sutton T, Fok J, Albanese F, Mathie H, & Holland R: Factors associated with access to care and healthcare utilization in the homeless population of England. JPH: advanced access: 2016 pp. 1–8 | doi:10.1093/pubmed/fdw008
39. Adams R, Barton G, Bhattacharya D, Grassby P, Holland R, Howe A, Norris et al: Supervised pharmacy student led medication review in primary care for patients with type 2 diabetes: A randomised controlled pilot study. BMJ Open: 11/2015; 5(11):e009246. DOI: 10.1136/bmjopen-2015-009246
40. *Maskrey V, Blyth A, Brown T, Barton G, Notley C, Aveyard P, Holland R, Bachmann, Sutton S, Leonardi-Bee J, Brandon T, Song F: Self-help educational booklets for the prevention of smoking relapse following smoking cessation treatment: a randomised controlled trial. Addiction Volume 110, Issue 12, pages 2006–2014, December 2015
41. Blyth A et al: Effectiveness and economic evaluation of self-help material for prevention of smoking relapse. Randomised controlled trial. HTA monograph; Volume: 19 Issue: 59 July 2015; DOI: http://dx.doi.org/10.3310/hta19590
42. Notley C, Blyth A, Craig J, Edwards A, Holland R. Postpartum Smoking Relapse - A thematic synthesis of qualitative studies. Addiction Volume 110, Issue 11, pages 1712–1723, November 2015
43. Cate H, Bhattacharya D, Holland R, Clark A, Broadway D: A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial. Clinical Trials, 1-10, DOI: 10.1177/1740774515592636
44. Neilson A et al: Pharmacist-led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial. BMJ Open 2015;5:e006874 doi:10.1136/bmjopen-2014-006874
45. Wade, R et al: Radial Artery Blood Gas Sampling: A Randomised Controlled Trial of Lidocaine Local Anaesthesia. Journal of Evidence Based medicine: 2015 Vol 8 (4), pages 185–191
46. Fielding S, Porteous T, Ferguson J, Maskrey V, Blyth A, Paudyal V, Barton G, Holland R, Bond C, Watson M. Estimating the burden of minor ailment consultations in general practices and emergency departments through retrospective review of routine data in North East Scotland. Family Practice, Fam Pract. 2015 Apr;32(2):165-72. doi: 10.1093/fampra/cmv003.
47. Hohl C, et al. The Effect of Early In-hospital Medication Review on Health Outcomes: A Systematic Review. BJCP Volume 80, Issue 1, pages 51–61, July 2015
48. Watson M, et al. A cohort study of influences, health outcomes and costs of patients’ health seeking behaviour for minor ailments from primary and emergency care settings. In press: BMJ Open 2015 Feb 18;5(2):e006261. doi: 10.1136/bmjopen-2014-006261
49. Sach T, Houghton J, Holland R, Desborough D. Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older people. IJPP 2014 Volume 23, Issue 4, pages 237–247, August 2015
50. Kidd A, Honney K, Myint P, Holland R, Bowker L. Does medical futility matter in ‘do not attempt CPR’ decision-making? IJCP 2014 Volume 68, Issue 10, pages 1190–1192, October 2014
51. Notley C, Blyth A, Maskrey V, Pinto H, Holland R. Exploring the concepts of abstinence and recovery through the experiences of long term opiate substitution clients. Substance Abuse 2014, DOI:10.1080/08897077.2014.941085
52. Cate H, Bhattacharya D, Clark A, Fordham R, Holland R, Broadway D: Improving adherence to glaucoma medication: a randomized controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study). BMC Ophthalmology 14:32 (24 March 2014)
53. Croxford A, Notley C, Maskrey V, Holland R, Kouimtsidis C: An exploratory qualitative study seeking participant views evaluating group Cognitive Behavioural Therapy preparation for alcohol detoxification. Journal of Substance Use, online from Nov 2014 (doi:10.3109/14659891.2014.894590)
54. *Holland R, Maskrey V, Swift L, Notley C, Robinson A, Nagar J, Gale T, Kouimtsidis C: Treatment retention, drug use and social functioning outcomes in those receiving three months versus one month of supervised opioid maintenance treatment. Results from the Super C randomised controlled trial. Addiction 2014: 109 (4), 596-607
55. Fingleton N, Matheson C, Holland R,: Specialist clinicians' practice and views regarding methadone/buprenorphine supervision and contingency management: a national survey. J. Substance Use 2013 published online Dec 2013: doi: 10.3109/14659891.2013.858781
56. Notley C, Maskrey V, Nagar J, Kouimtsidis C, Holland R. Regaining control: The patient experience of supervised compared to unsupervised consumption in Opiate Substitution Treatment. Drug and Alcohol Review 2014: 33(1), 64-70
57. Salter C, McDaid, L, Bhattacharya D, Holland R, Marshall T, Howe A: Abandoned Acid? Understanding Adherence to Bisphosphonate Medications for the Prevention of Osteoporosis among Older Women: A Qualitative Longitudinal Study. PLoS ONE 2014: 9(1): e83552. doi:10.1371/journal.pone.0083552
58. Maas J, Holland R, Pinto H, Maskrey V, Barton G: Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment. Drug Alcohol Depend. (2013),133(2):494-501
59. Paudyal V, Watson MC, Sach T, Porteous T, Bond CM, Wright D, Cleland J, Barton G, Holland, R. Are pharmacy-based Minor Ailment Schemes a substitute for other service providers? A systematic review. Br J Gen Pract 2013 63; 612:359-362.
60. Borrows A, Holland R: A Pilot Randomised Controlled Trial of the Occupational Therapy Service from an Independent Living Centre Vs. Routine Community Occupational Therapy Service. Int J. Therapy & Rehab April 2013, Vol 20, No 4, 187-194
61. Bruhn H, Bond CM, Elliott AM et al: Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. BMJ Open 2013;3:e002361.doi:10.1136/bmjopen-2012-002361
62. Notley C, Maskrey V, Blyth A, Craig J, Holland R: The Experience of Long Term Opiate Maintenance Treatment and Reported Barriers to Recovery - A Qualitative Systematic Review. European Addiction Research 2013;19:287-298 (DOI: 10.1159/000346674)
63. Cate H, Bhattacharya D, Clark A, Fordham R, Holland R, Notley N, Broadway D: Patterns of adherence behaviour for patients with glaucoma. Eye, 2013: doi:10.1038/eye.2012.294
64. Cate H, Bhattacharya D, Clark A, Fordham R, Holland R, Notley N, Broadway D: Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management. BMC Ophthalmology; 2012, 12:57. DOI: 10.1186/1471-2415-12-57
65. Rutter C, Dhetariya K, Wilson E, Jones C, Holland R, Bradley C, et al: Determining inpatient diabetes treatment satisfaction in the UK - the DIPSat study: Diabetes medicine 2013; 30 (6), 731-738
66. Kwok C, Gibbs S, Bennett C, Holland R, Abbot R. Topical treatments for cutaneous warts: Cochrane database of systematic reviews, Sep 2012: DOI: 10.1002/14651858.CD001781.pub3
67. Gega L et al: Computerised therapy for depression with clinician vs. Assistant and brief vs. Extended phone support: study protocol for a randomised controlled trial. BMC Trials 2012, 13:151; http://www.trialsjournal.com/content/13/1/151
68. Kemm J, Rumball D, Badrakalimuthu R, Holland R: Factors influencing the use of dental health services by substance users: a study paper. SMMGP August 2012
69. Song F, et al: Self-help materials for prevention of smoking relapse: protocol for a RCT: Trials 2012; 13(1): article no. 69
70. Smith J, Wilson A, et al: The At-Risk Registers in Severe Asthma (ARRISA) Study: a cluster-randomised controlled trial examining effectiveness and costs in primary care. Thorax 2012;67:12 1052-1060 Published Online First: 31 August 2012
71. Jennings A, Cassidy A, Winters T, Barnes S, Lipp A, Holland R & Welch A. Positive effect of a targeted intervention to improve access and availability of fruit and vegetables. Health & Place 2012, 18 (5):1074-1078
72. Song F, Loke Y, Altman D, et al Assessment of trial similarity and evidence consistency for indirect treatment comparisons: an empirical investigation Journal of Clinical Epidemiology 2013 February; 66(2): 184–191.
73. Desborough J, Sach T, Bhattacharya, D, Holland R, Wright D. A cost-consequences analysis of an adherence focused pharmacist-led medication review service. Article first published online: 20 SEP 2011, DOI: 10.1111/j.2042-7174.2011.00161.x
74. Shepstone L., R. Fordham R, E. Lenaghan E., Harvey I, Cooper C, et al: A pragmatic randomised controlled trial of the effectiveness and cost effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the ‘SCOOP’ Study. Osteoporosis International. 2012, 23 (10): 2507-2515
75. Abdelhamid A, Song F, et al: Use of indirect comparison methods in systematic reviews: a survey of Cochrane review authors. Research Synthesis Methods 2012, 3(2): 71–79
76. Hammouche S, Holland R, Steel N. Does quality of care for hypertension in primary care vary with postcode area deprivation? An observational study. Does quality of care for hypertension in primary care vary with postcode area deprivation? An observational study. BMC Health Services Research 2011, 11:297
77. Holland R, Matheson C, Bond C, Anthony G. A pilot randomised controlled trial of brief vs. twice weekly vs. standard supervised consumption in patients on opiate maintenance treatment. Drug & Alcohol Review 2012, 31 (4): 483–491
78. Song F, Xiong T, Parekh-Bhurke S, Loke Y, Sutton A, Eastwood A, Holland R, Chen Y, Glenny A, Deeks J, Altman D: Discrepancy between direct and adjusted indirect comparison: a meta-epidemiological study. BMJ 2011;343:doi:10.1136/bmj.d4909
Desborough J, Houghton J, Wood J, Wright D, Holland R, Sach T, Ashwell S and Shaw V: Multi-professional clinical medication reviews in care homes for the elderly: study protocol for a randomised controlled trial with cost effectiveness analysis. Trials 2011, 12:218
Anthony G, Matheson C, Holland R, Bond C et al Methadone Prescribing under Supervised Consumption on Premises (COP); A Scottish Clinicians Perspective on Prescribing Practice. Drug and Alcohol Review 2012: 31 (3): 342–347
Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. BJ Dermatology; 2011; 165: 233–246
Notley C, Maskrey V, Holland R. The needs of problematic drug misusers not in structured treatment – a qualitative study of perceived treatment barriers and recommendations for services. Drugs Education Prevention and Policy 2012; 19(1): 40–48
Pinto H, Maskrey, V, Rumball D, Swift L, Wagle A, Holland R: The SUMMIT trial. A field comparison of subutex vs. methadone maintenance treatment. Journal of Substance Abuse Treatment 2010 Dec; 39(4): 340-52
Holland, R., Rechel, B., Stepien, K., Harvey, I., and Brooksby, I. Patients' self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death. Journal Cardiac Failure 2010; 16: 150-6.
Song F, Huutunen Lenz M, Holland R. Effectiveness of complex psycho-educational interventions for smoking relapse prevention: an exploratory meta-analysis. JPH 2009; doi: 10.1093/pubmed/fdp109
Uddin, M, Maskrey V, Holland R. A Study to Validate A Self-Reported Version Of The ONS Drug Dependence Questionnaire. Journal of Substance Use 2011; 16(4): 273–281.
Broadbent J, Maisey S, Holland R, Steel N. Recorded quality of primary care of osteoarthritis: an observational study. BJGP 2009: 58 (557); 839-843.
Rechel, B., Spencer, N., Blackburn, C., Holland, R., and Rechel, B. Impact of health reforms on child health services in Europe: the case of Bulgaria. Eur J Public Health, 19: 326-30.
Tam, M. D., Hart, A. R., Williams, S. M. et al. Evaluation of a computer program ('disect') to consolidate anatomy knowledge: a randomised-controlled trial. Med Teach 2010, 32: e138-42.
Desborough JA, Butters P, Bhattacharya D, Holland RC, Wright DJ. Does it matter whether the recipient of patient questionnaires in general practice is the general practitioner or an independent researcher? The REPLY randomised trial. BMC Medical Research Methodology 2008; 8 (42): DOI: 10.1186/1471-2288-8-42
Holland R, Desborough J, Loke Y et al. A systematic review of medication review by pharmacists in older people. Br J Clin Pharmacol 2008: 65(3); 303-316
Pinto H, Rumball D, Maskrey V, Holland R: A pilot study for a RCT and patient preference trial of buprenorphine versus methadone maintenance treatment in the management of opiate dependent patients. Journal of Substance Use 2008, 13 (2), 73-82
Pinto H, Rumball D, Holland R: Attitudes and knowledge of substance misusers regarding buprenorphine and methadone maintenance therapy. Journal of Substance Use 2008, 13 (3), 143-153
Smith JR. Mugford M. Holland R. Noble MJ. Harrison BDW: Psycho-educational interventions for adults with severe or difficult asthma: A systematic review. Journal of Asthma 2007. 44(3), 219-241
Holland R, Brooksby I, Lenaghan E et al. The effectiveness of visits from community pharmacists for patients with heart failure? HeartMed randomised controlled trial. BMJ 2007 (334) 1098-1101
Salter C, Holland R, Harvey I, & Henwood K: “I haven’t even phoned my doctor yet”. The advice giving role of the pharmacist during medication review consultations: qualitative discourse analytic study: BMJ 2007 (334) 1101-3
Holland R, Rechel B, Wright D: Effects of telephone counselling on mortality and adherence. [Research Review] Prescriber 2007 18(1), 16-29
Lenaghan E, Brooks A, Holland R. Home-based medication review in a high risk elderly population in primary care – The POLYMED randomised controlled trial. Age Ageing. 2007 May; 36(3):292-7
Thomas KS, Keogh-Brown MK, Chalmers JR, Fordham RC, Holland RC, Armstrong SJ, Bachmann M, Howe AH, Rodgers S, Avery AJ, Harvey I, Williams HC Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. Br. J. Dermatology 2007; 156(4): 687-692.
Pacini M, Smith RS Wilson ECF, Holland R. Home based medication review in older people, is it cost effective? Pharmacoeconomics 2007 25(2), 171-180.
Thomas KS, Keogh-Brown MK, Chalmers JR, Fordham RC, Holland RC, Armstrong SJ, Bachmann M, Howe AH, Rodgers S, Avery AJ, Harvey I, Williams HC Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model. Health Technol Assess 2006; 10(25):1-104.
Holland R, Vivancos R, Maskrey V, Sadler J, Rumball D, Swift L. The prevalence of problem drug misuse in a rural county of England. Journal of Public Health 2006; 28(2): 88-95.
Vivancos R, Maskrey V, Rumball D, Harvey I, Holland R. Crack cocaine use in a rural county of England. Journal of Public Health 2006; 28(2): 96-103.
Song F, Jerosch-Herold, C, Holland R, de Lourdes Drachler M, Mares K, Harvey I. Statistical methods for analysing Barthel scores in trials of post-stroke interventions: a review and computer simulations. Clinical Rehabilitation 2006; 20: 347-356.
Holland R, Hoysal N, Gilmore A, Acquilla S. Quality of training in Public Health in the United Kingdom: Results of the First National Training Audit. Public Health 2006; 120, 237-248.
Holland R, Hoysal N, Gilmore A, Acquilla S. Insights into training and exam performance from the 1st UK National Public Health Training Audit. Public Health 2006; 120, 249-255.
Greenwood K, Howe A, Holland R. The use of consultation skills assessment tools in pharmacist – patient consultations. Int J Pharm Pract 2006; 14: 277-282
Holland R, Lenaghan E, Harvey I, Smith R, Lipp A et al. Delivering a home-based medication review, process measures from the HOMER randomised controlled trial. Int. J Pharm Pract 2006 14: 71-79.
Holland R, Wright D. Medication Review for Older Adults. Geriatrics & Aging 2006; 9 (3), 203-209.
Holland R, Smith R, Harvey, I. Where now for pharmacist-led medication review. J Epidemiol Community Health 2006 60: p. 92-93.
Smith J, Mugford M, Holland R, Candy B, et al. A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma. Health Technol Assess. 2005 9(23): 1-182.
Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. A systematic review of multidisciplinary interventions in heart failure. Heart 2005; 91(7): 899-906.
Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A et al. Does home based medication review keep older people out of hospital? The HOMER randomized controlled trial. BMJ 2005; 330 293-295.
Holland R, Smith R, Harvey I, E. Lenaghan, Swift L. Measuring quality of life in the elderly, a direct comparison of the EQ-5D and AQoL: Health Economics 2004; 13 793-805.
Raithatha N, Holland R, Gerard S, Harvey I. A qualitative investigation of vaccine risk perception amongst parents who immunise their children: a matter of public health concern, J Public Health Med 2003; 25 161-164.
Holland R & Harvey I. Population needs and knee replacement surgery, Rheumatology 2003; 42 503-506.
Holland R & Harvey I. Adult versus childhood susceptibility to melanoma: is there a difference? Archives of Dermatology 2002 Sep;138 (9) 1234-5.
Holland R, Harvey I, Harrison B. The benefits of providing GPs with the results of a Confidential Enquiry into Asthma Deaths. Primary Care Respiratory Journal 2002; 11 (3) 103-104.
Holland R, Harvey I, Shepstone L. An analysis of predictors of success in Part II MFPHM, J Public Health Med 2002; 24 58-62.
Bhattacharya D, Aldus C, Barton G, Bond C, Charles, I, Fleetcroft R, Holland R et al. Do not initiate medication organisation devices without prior detailed medication review and vigilant monitoring. BMJ Letter: http://www.bmj.com/content/330/7486/293/rr/774082
I have always had a passion for teaching and played an active role in UEA's new innovative integrated medical course. I became its Course Director in 2008 and Deputy Head of School in 2012. My team successfully navigated a period of student growth, enhanced standards of admission, teaching quality and assessment, and re-designed the final two years' curriculum to establish a longer student assistantship. By 2015 UEA graduates were reporting that they were some of the best prepared in the country, alongside high levels of student satisfaction.
I was appointed Head of Leicester Medical School in 2017 and have worked with our excellent team to deliver a new curriculum designed by Nick London et al, with a strong focus on clinical apprenticeship training. The new curriculum has bedded in well, whilst simultaneously we have grown our intake by over 30% growth, made gains in student satisfaction (now top 10 in UK), and improved the preparedness of our graduates.
Aside from my undergraduate role, I chaired the Part A exam for the Faculty of Public Health (the first stage knowledge exam in Public health training); I now chair the Diplomate Exam Development Committee, and I have trained many academic clinical Public Health trainees.